製品名:propan-2-ylurea

IUPAC Name:(propan-2-yl)urea

CAS番号:691-60-1
分子式:C4H10N2O
純度:95%+
カタログ番号:CM695171
分子量:102.14

包装単位 有効在庫 価格(USD) 数量
CM695171-5g in stock ňňƅ
CM695171-10g in stock șƩș

研究開発用専用.

問い合わせフォーム

   refresh    

製品詳細

CAS番号:691-60-1
分子式:C4H10N2O
融点:-
SMILESコード:CC(C)NC(N)=O
密度:
カタログ番号:CM695171
分子量:102.14
沸点:
MDL番号:MFCD00047875
保管方法:

Category Infos

Aliphatic Chain Compounds
Aliphatic chain compounds include aliphatic compounds and chain compounds containing other elements or groups. Aliphatic hydrocarbons are hydrocarbons with the basic properties of aliphatic compounds. In aliphatic compounds, carbon atoms are arranged in straight chain, branched chain or cyclic, which are respectively called straight chain aliphatic hydrocarbons, branched chain aliphatic hydrocarbons and alicyclic hydrocarbons. Some cyclic hydrocarbons are different in nature from aromatic hydrocarbons, and are very similar to aliphatic hydrocarbons. Such cyclic hydrocarbons are called alicyclic hydrocarbons. In this way, aliphatic hydrocarbons become a general term for all hydrocarbons except aromatic hydrocarbons. Aliphatic hydrocarbons and their derivatives (including halogenated hydrocarbons) and alicyclic hydrocarbons and their derivatives are collectively referred to as aliphatic compounds.

Column Infos

Mavacamten
CAMZYOS(Mavacamten) was recently approved in the European Union, following its approval in the U.S. and other markets worldwide, and is the first and only cardiac myosin inhibitor approved to treat adult patients with symptomatic obstructive hypertrophic cardiomyopathy(HCM).
Mavacamten is a first-in-class, targeted inhibitor of cardiac myosin, reduces the number of myosin-actin cross-bridges and thus decreases excessive contractility characteristic of HCM.

Related Products